Vaxxinity, Inc. (VAXX) Financials

VAXX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 57.5 million 33.8 million
2023-06-30 71.4 million 36.4 million
2023-03-31 85.5 million 39.4 million
2022-12-31 106.4 million 44.2 million

VAXX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.3 million 1.8 million
2023-06-30 -12.2 million 2.4 million
2023-03-31 -20.2 million 2.2 million
2022-12-31 -14.8 million 2.4 million

VAXX Net Income

No data available :(

VAXX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 42.5 million - -
2023-06-30 55.8 million - -
2023-03-31 67.6 million - -
2022-12-31 86.8 million 9.9 million -

VAXX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 126.7 million
2023-06-30 126.5 million
2023-03-31 126.1 million
2022-12-31 125.9 million

VAXX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 127000 7.9 million 5.5 million -
2023-06-30 90000 8.3 million 6.1 million -
2023-03-31 172000 11.4 million 7.4 million -
2022-12-31 292000 13.0 million 7.8 million -

VAXX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 666000
2023-06-30 - 512000
2023-03-31 - 600000
2022-12-31 - 540000

VAXX

Price: $0.12

52 week price:
0.12
3.10

Earnings Per Share: -0.45 USD

P/E Ratio: -1.34

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 380403

Market Capitalization: 61.8 million

Links: